SGLT2 Inhibition and Left Ventricular Mass

NCT02728453 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment.

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Empagliflozin
DRUG: Glimepiride

Sponsor

Hannover Medical School

Collaborators

[object Object]